Clinical Trial Update: Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of P1101 in polycythemia vera patients with difficult-to-treat standard therapies. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• P1101

Snippet

Sponsor: PharmaEssentia Japan K.K. | Conditions: Polycythemia Vera (PV) | Phase 2 | Status: COMPLETED | Results posted: 2025-09-15